Download Docs
Export
Print

SPARX PROTEINS

88861339 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed April 6, 2020
Serial No. 88861339
Examining Attorney AUDREY RICKS
Interlocutory Attorney CHARLES HISER
Class Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for use in cancer treatment and immunotherapy; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors for use in cancer treatment and immunotherapy; none of the foregoing for gene therapy or for the diagnosis or treatment of genetic, retinal, or hematologic diseases and disorders; 005; 006; 018; 044; 046; 051; 052
SPARX PROTEINS
Case Type Trademark
Status Abandoned after an inter partes decision by the Trademark Trial and Appeal Board. For further information, see TTABVUE on the Trademark Trial and Appeal Board web page.
Opposition 91294507
Spark Therapeutics, Inc. v. Arcellx, Inc.
  • Arcellx, Inc.;
  • Spark Therapeutics, Inc.;
Opposition 88861339
Spark Therapeutics, Inc. v. Arcellx, Inc.
  • Arcellx, Inc.;
  • Spark Therapeutics, Inc.;
Last Updated: 10 months, 2 weeks ago
Filing Date # Docket Text